Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Angiotech Pharmaceuticals, Inc. > News item |
Interinvest reports 6.22% stake in Angiotech
By Jennifer Chiou
New York, Jan. 30 - Angiotech Pharmaceuticals, Inc. investor Interinvest Corp. Inc. reported a 6.22% stake in the company after a series of purchases between Dec. 9 and Jan. 29, according to a schedule 13D/A filed with the Securities and Exchange Commission.
Interinvest beneficially owns 5,295,850 shares of the Vancouver, B.C.-based specialty pharmaceutical and medical device company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.